Prolacta Bioscience
Human milk-based nutritional products
- B2B
- B2G
About Prolacta Bioscience
A life sciences company dedicated to advancing human milk science to provide critically ill infants with human milk-based nutritional products nationwide
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- City of Industry, California, United States
- Founded
- 1999
- Revenue
- $24.9M – $196MTamtam estimate
- Website
- prolacta.com
Prolacta Bioscience in the news
- Human Milk Bank Management Market Poised for Significant Expansion |• Medolac Laboratories • Prolacta Bioscience
The Human Milk Bank Management Market is projected to expand notably, with key players like Prolacta Bioscience involved, driven by technological and regulatory developments across global regions.
- Majority of U.S. Level III & IV NICUs in 2025 Used Prolacta's 100% Breastmilk-Based Fortifiers & Formulas to Improve Outcomes for Premature Infants
In 2025, most U.S. top-level NICUs used Prolacta's 100% breastmilk-based fortifiers and formulas, improving survival and development in premature infants.
- Majority of U.S. Level III & IV NICUs in 2025 Used Prolacta's 100% Breastmilk-Based Fortifiers & Formulas to Improve Outcomes for Premature Infants
In 2025, most U.S. high-level NICUs used Prolacta's 100% breastmilk-based fortifiers and formulas, improving survival and development in extremely premature infants by avoiding cow milk and synthetic ingredients.
- Majority of U.S. Level III & IV NICUs in 2025 Used Prolacta's 100% Breastmilk-Based Fortifiers & Formulas to Improve Outcomes for Premature Infants
In 2025, most U.S. top-level NICUs used Prolacta's 100% breastmilk-based fortifiers and formulas, improving survival and development for extremely premature infants by avoiding cow milk and synthetic ingredients.
- Prolacta Bioscience: Safe Nutrition For Premature Infants
Proper nutrition in the early days is crucial for the care and progress of premature infants, as highlighted during Prematurity Awareness Month.
Prolacta Bioscience at a glance
Prolacta Bioscience is a B2B/B2G company in the Biotechnology Research industry, headquartered in City of Industry, California, United States.
Prolacta Bioscience was founded in 1999.
Prolacta Bioscience has 251–1,000 employees.
Prolacta Bioscience's revenue is $24.9M – $196M (Tamtam estimate).
Selling to companies like Prolacta Bioscience?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies